• Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC

    9 days ago - By MedPageToday

    A first-line immune checkpoint inhibitor combination of nivolumab plus ipilimumab improved survival in patients with advanced non-small cell lung cancer when added to a limited course of chemotherapy...
    Read more ...